Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

4 entries on 1 page. Showing entries 1 - 4.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 22 c.2380C>T r.(?) p.(Gln794*) Hamartin binding domain - Unknown - pathogenic g.2124225C>T g.2074224C>T - - TSC2_000456 - originally Kwiatkowski database - - Germline - - - - - DNA ? Blood - TSC - originally Kwiatkowski database - ? - - - - - - - 1 Rosemary Ekong
+/. 22 c.2380C>T r.(?) p.(Gln794*) Hamartin binding domain - Unknown - pathogenic g.2124225C>T g.2074224C>T Q794* - TSC2_000456 variant in kidney tumour + chr 16 LOH; seen with entire del TSC2 gene in different tumour; tumour & matched normal tissue DNA tested; NGS coverage median 570x; exon coverage analysis >100x, whole-exome analysis depth >85x; Sanger SEQ done PubMed: Voss, 2014 - - Somatic - - - - - DNA SEQ-NG-I, SEQ Kidney - ? - PubMed: Voss, 2014 17 yr old patient with metastatic RCC, bilateral kidney tumours and TSC; patient has biallelic loss of entire TSC2 gene seen in 1 kidney tumour; occurs with TSC2 c.2380C>T in a 2nd kidney tumour; NGS on Illumina HiSeq 2000 M - - - - - - - 1 Rosemary Ekong
+/. 22 c.2380C>T r.(?) p.(Gln794*) - - Maternal (confirmed) ACMG pathogenic (dominant) g.2124225C>T g.2074224C>T - - TSC2_000456 - PubMed: Ding, 2020 - - Germline - - - - - DNA SEQ - - TSC 91 PubMed: Ding, 2020 - M - China - - - - - 1 Yifeng Ding
+/+ 22 c.2380C>T r.(?) p.(Gln794*) Hamartin binding domain - Unknown - pathogenic (dominant) g.2124225C>T g.2074224C>T - - TSC2_000456 - - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.